A study of NouvSoma001 for recent stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a new treatment called NouvSoma001 for people who have had an ischemic stroke within the last week. It aims to see if the treatment is safe and helps improve muscle strength and overall recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You had an ischemic stroke (blocked artery in the brain) no more than 7 days ago.
- Your stroke symptoms are moderate to moderately severe (NIHSS score 6–20) and you have weakness in at least one arm or leg.
- You can understand the study and give consent, or have a legal representative who can.
- You do not have bleeding in the brain, other brain conditions like tumors or Parkinson's, or serious infections or organ problems.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a nasal spray made from stem cell particles can help people recover after an ischemic stroke. It is for adults who had a stroke within the last two weeks and did not receive clot-busting treatment.
This trial tests whether a special type of stem cell (from umbilical cord) can help people recover after a recent ischemic stroke. It aims to see if this treatment can improve movement and reduce disability.
This trial tests whether a patient's own bone marrow stem cells, given through a vein, can help improve recovery after a stroke. It is for people who had a moderate stroke 3 to 12 months ago and still have some disability.
This trial tests a new gene therapy called NXL-001 for people who still have moderate to severe arm or leg weakness 2 to 12 months after a stroke. The treatment aims to help the brain repair itself and improve movement.
This trial tests if combining two kinds of gentle brain stimulation can help people recover better after a recent stroke. It's for people who had a clot-caused stroke in the upper part of the brain and still have some weakness on one side.
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.